UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 29

Sortiert nach

Chemokine receptor inhibition by AMD3100 is strictly confined to CXCR4

FEBS letters, 2002-09, Vol.527 (1-3), p.255-262

2002

Volltextzugriff (PDF)

Modifying Rap1-signalling by targeting Pde6δ is neuroprotective in models of Alzheimer's disease

Molecular neurodegeneration, 2018-09, Vol.13 (1), p.50-50, Article 50

2018

Volltextzugriff (PDF)

HIV chemokine receptor inhibitors as novel anti-HIV drugs

Cytokine & growth factor reviews, 2005-12, Vol.16 (6), p.659-677

2005

Volltextzugriff (PDF)

Mannose-Specific Plant Lectins from the Amaryllidaceae Family Qualify as Efficient Microbicides for Prevention of Human Immunodeficiency Virus Infection

Antimicrobial Agents and Chemotherapy, 2004-10, Vol.48 (10), p.3858-3870

2004

Volltextzugriff (PDF)

AMD3465, a monomacrocyclic CXCR4 antagonist and potent HIV entry inhibitor

Biochemical pharmacology, 2005-09, Vol.70 (5), p.752-761

2005

Volltextzugriff (PDF)

Inhibition of Human Immunodeficiency Virus Replication by a Dual CCR5/CXCR4 Antagonist

Journal of Virology, 2004-12, Vol.78 (23), p.12996-13006

2004

Volltextzugriff (PDF)

The role of N-glycosylation sites on the CXCR4 receptor for CXCL-12 binding and signaling and X4 HIV-1 viral infectivity

Virology (New York, N.Y.), 2007-07, Vol.363 (2), p.280-287

2007

Volltextzugriff (PDF)

Modest Human Immunodeficiency Virus Coreceptor Function of CXCR3 Is Strongly Enhanced by Mimicking the CXCR4 Ligand Binding Pocket in the CXCR3 Receptor

Journal of Virology, 2007-04, Vol.81 (7), p.3632-3639

2007

Volltextzugriff (PDF)

Pharmacological modulation of septins restores calcium homeostasis and is neuroprotective in models of Alzheimer's disease

Science (American Association for the Advancement of Science), 2024-05, Vol.384 (6699), p.eadd6260

2024

Volltextzugriff (PDF)

Discovery of Novel Small Molecule Orally Bioavailable C−X−C Chemokine Receptor 4 Antagonists That Are Potent Inhibitors of T-Tropic (X4) HIV-1 Replication

Journal of medicinal chemistry, 2010-04, Vol.53 (8), p.3376-3388

2010

Volltextzugriff (PDF)

Fluorescent CXCL12AF647 as a novel probe for nonradioactive CXCL12/CXCR4 cellular interaction studies

Cytometry. Part A, 2004-10, Vol.61A (2), p.178-188

2004

Volltextzugriff (PDF)

Derailed Intraneuronal Signalling Drives Pathogenesis in Sporadic and Familial Alzheimer’s Disease

BioMed research international, 2014-01, Vol.2014, p.167024-14

2014

Volltextzugriff (PDF)

Modifying Rap1-signalling by targeting Pde6[delta] is neuroprotective in models of Alzheimer's disease

Molecular neurodegeneration, 2018-09, Vol.13 (1)

2018

Volltextzugriff (PDF)

Establishment of a novel CCR5 and CXCR4 expressing CD4+ cell line which is highly sensitive to HIV and suitable for high-throughput evaluation of CCR5 and CXCR4 antagonists

Retrovirology, 2004-03, Vol.1 (1), p.2-2

2004

Volltextzugriff (PDF)

Synthesis and Structure−Activity Relationships of Azamacrocyclic C-X-C Chemokine Receptor 4 Antagonists: Analogues Containing a Single Azamacrocyclic Ring are Potent Inhibitors of T-Cell Tropic (X4) HIV-1 Replication

Journal of medicinal chemistry, 2010-02, Vol.53 (3), p.1250-1260

2010

Volltextzugriff (PDF)

CADA, a novel CD4-targeted HIV inhibitor, is synergistic with various anti-HIV drugs in vitro

AIDS (London), 2004-11, Vol.18 (16), p.2115-2125

2004

Volltextzugriff (PDF)

Molecular cloning and expression of a chicken pituitary adenylate cyclase-activating polypeptide receptor

Brain research. Molecular brain research., 1999-08, Vol.71 (2), p.244-255

1999

Volltextzugriff (PDF)

Mutation of Asp(171) and Asp(262) of the chemokine receptor CXCR4 impairs its coreceptor function for human immunodeficiency virus-1 entry and abrogates the antagonistic activity of AMD3100

Molecular pharmacology, 2001-07, Vol.60 (1), p.164-173

2001

Volltextzugriff (PDF)

Evaluation of SDF‐1/CXCR4‐induced Ca2+ signaling by fluorometric imaging plate reader (FLIPR) and flow cytometry

Cytometry. Part A, 2003-01, Vol.51A (1), p.35-45

2003

Volltextzugriff (PDF)

Mutations at the CXCR4 interaction sites for AMD3100 influence anti-CXCR4 antibody binding and HIV-1 entry

FEBS letters, 2003-07, Vol.546 (2), p.300-306

2003

Volltextzugriff (PDF)

CADA Inhibits Human Immunodeficiency Virus and Human Herpesvirus 7 Replication by Down-modulation of the Cellular CD4 Receptor

Virology (New York, N.Y.), 2002-10, Vol.302 (2), p.342-353

2002

Volltextzugriff (PDF)

Fluorescent CXCL12 AF647 as a novel probe for nonradioactive CXCL12/CXCR4 cellular interaction studies

Cytometry. Part A, 2004-10, Vol.61A (2), p.178-188

2004

Volltextzugriff (PDF)

CADA, a novel CD4-targeted HIV inhibitor, is synergistic with various anti-HIV drugs in vitro. Commentary

AIDS (London), 2004, Vol.18 (16), p.2115-2125

2004

Volltextzugriff (PDF)

Establishment of a novel CCR5 and CXCR4 expressing CD4 super(+ )cell line which is highly sensitive to HIV and suitable for high-throughput evaluation of CCR5 and CXCR4 antagonists

Retrovirology, 2004-01, Vol.1

2004

Volltextzugriff (PDF)

The antiviral activity of the CXCR4 antagonist AMD3100 is independent of the cytokine-induced CXCR4/HIV coreceptor expression level

AIDS research and human retroviruses, 2003-12, Vol.19 (12), p.1135-1139

2003

Volltextzugriff (PDF)

1 – 25 von 29

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(29)
Mit Volltextzugriff
(29)

Publikationsform

Artikel
(29)

Sprache

Englisch
(29)
Japanisch
(7)

Erscheinungsjahr

n.n

Zeitschrift / Serie

Cytometry. Part A
(4)
Molecular Pharmacology
(3)
Aids
(2)
Febs Letters
(2)
Journal Of Medicinal Chemistry
(2)
Journal Of Virology
(2)
Molecular Neurodegeneration
(2)
Retrovirology
(2)
Virology
(2)
Aids Research And Human Retroviruses
(1)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Chemokine receptor inhibition by AMD3100 is strictly confined to CXCR4

Modifying Rap1-signalling by targeting Pde6δ is neuroprotective in models of Alzheimer's disease

HIV chemokine receptor inhibitors as novel anti-HIV drugs

Mannose-Specific Plant Lectins from the Amaryllidaceae Family Qualify as Efficient Microbicides for Prevention of Human Immunodeficiency Virus Infection

AMD3465, a monomacrocyclic CXCR4 antagonist and potent HIV entry inhibitor

Inhibition of Human Immunodeficiency Virus Replication by a Dual CCR5/CXCR4 Antagonist

The role of N-glycosylation sites on the CXCR4 receptor for CXCL-12 binding and signaling and X4 HIV-1 viral infectivity

Modest Human Immunodeficiency Virus Coreceptor Function of CXCR3 Is Strongly Enhanced by Mimicking the CXCR4 Ligand Binding Pocket in the CXCR3 Receptor

Pharmacological modulation of septins restores calcium homeostasis and is neuroprotective in models of Alzheimer's disease

Discovery of Novel Small Molecule Orally Bioavailable C−X−C Chemokine Receptor 4 Antagonists That Are Potent Inhibitors of T-Tropic (X4) HIV-1 Replication

Fluorescent CXCL12AF647 as a novel probe for nonradioactive CXCL12/CXCR4 cellular interaction studies

Derailed Intraneuronal Signalling Drives Pathogenesis in Sporadic and Familial Alzheimer’s Disease

Modifying Rap1-signalling by targeting Pde6[delta] is neuroprotective in models of Alzheimer's disease

Establishment of a novel CCR5 and CXCR4 expressing CD4+ cell line which is highly sensitive to HIV and suitable for high-throughput evaluation of CCR5 and CXCR4 antagonists

Synthesis and Structure−Activity Relationships of Azamacrocyclic C-X-C Chemokine Receptor 4 Antagonists: Analogues Containing a Single Azamacrocyclic Ring are Potent Inhibitors of T-Cell Tropic (X4) HIV-1 Replication

CADA, a novel CD4-targeted HIV inhibitor, is synergistic with various anti-HIV drugs in vitro

Molecular cloning and expression of a chicken pituitary adenylate cyclase-activating polypeptide receptor

Mutation of Asp(171) and Asp(262) of the chemokine receptor CXCR4 impairs its coreceptor function for human immunodeficiency virus-1 entry and abrogates the antagonistic activity of AMD3100

Evaluation of SDF‐1/CXCR4‐induced Ca2+ signaling by fluorometric imaging plate reader (FLIPR) and flow cytometry

Mutations at the CXCR4 interaction sites for AMD3100 influence anti-CXCR4 antibody binding and HIV-1 entry

CADA Inhibits Human Immunodeficiency Virus and Human Herpesvirus 7 Replication by Down-modulation of the Cellular CD4 Receptor

Fluorescent CXCL12 AF647 as a novel probe for nonradioactive CXCL12/CXCR4 cellular interaction studies

CADA, a novel CD4-targeted HIV inhibitor, is synergistic with various anti-HIV drugs in vitro. Commentary

Establishment of a novel CCR5 and CXCR4 expressing CD4 super(+ )cell line which is highly sensitive to HIV and suitable for high-throughput evaluation of CCR5 and CXCR4 antagonists

The antiviral activity of the CXCR4 antagonist AMD3100 is independent of the cytokine-induced CXCR4/HIV coreceptor expression level

Suchergebnisse filtern